Table I.
Associations between miR-3664-5P expression and clinicopathological characteristics of patients with GC (n=100).
| Clinicopathological features | Total n (n=100) | miR-3664-5P expression
|
P-value | |
|---|---|---|---|---|
| Low
|
High
|
|||
| No. of patients (%) | No. of patients (%) | |||
| Sex | 0.826 | |||
| Male | 71 | 36 (72.0) | 35 (70.0) | |
| Female | 29 | 14 (28.0) | 15 (30.0) | |
| Age, years | 0.406 | |||
| ≤50 | 64 | 30 (60.0) | 34 (68.0) | |
| >50 | 36 | 20 (40.0) | 16 (32.0) | |
| Differentiation | 0.016a | |||
| Well/ moderately | 56 | 22 (44.0) | 34 (68.0) | |
| Poor | 44 | 28 (56.0) | 16 (32.0) | |
| Clinical stage | 0.069 | |||
| I-II | 43 | 26 (52.0) | 17 (34.0) | |
| III-IV | 57 | 24 (48.0) | 33 (66.0) | |
| Tumor size (cm) | 0.016a | |||
| ≤3.5 | 50 | 19 (38.0) | 31 (52.0) | |
| >3.5 | 50 | 31 (52.0) | 19 (38.0) | |
| Lymph node metastasis | 0.420 | |||
| No | 44 | 20 (40.0) | 24 (48.0) | |
| Yes | 56 | 30 (60.0) | 26 (52.0) | |
| T classification | 0.838 | |||
| T1-T2 | 61 | 31 (62.0) | 30 (60.0) | |
| T3-T4 | 39 | 19 (38.0) | 20 (40.0) | |
Data were analyzed by Chi-squared test.
a
P<0.05. miR, microRNA.